Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy

Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and cardiac muscle are termed mesenchymal stem cells. These cells were first identified in the bone marrow, distinct from blood‐forming stem cells. Based on the embryologic derivation, availability, and various pro‐regenerative characteristics, research exploring their use in cell therapy shows great promise for patients with degenerative muscle diseases and a number of other conditions. In this review, the authors explore the potential for mesenchymal stem cell therapy in the emerging field of regenerative medicine with a focus on treatment for Duchenne muscular dystrophy.

[1]  D. Wolf,et al.  Mesenchymal stem cells as cellular immunosuppressants , 2008, The Lancet.

[2]  A. Lucia,et al.  Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury , 2006, British Journal of Sports Medicine.

[3]  B. Petersen,et al.  Stem cells in adult tissues. , 2002, Seminars in cell & developmental biology.

[4]  P. Bianco,et al.  Mesenchymal stem cells: revisiting history, concepts, and assays. , 2008, Cell stem cell.

[5]  K. Davies,et al.  Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration , 2006, Journal of Cell Science.

[6]  K. Oexle,et al.  Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging. , 2001, Neuropediatrics.

[7]  David Bryder,et al.  Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. , 2006, The American journal of pathology.

[8]  C. Zhang,et al.  Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells , 2007, Acta Pharmacologica Sinica.

[9]  K. Ando,et al.  In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells. , 2003, Experimental hematology.

[10]  J. Chamberlain,et al.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances. , 2007, Biochimica et biophysica acta.

[11]  Charlotte Collins,et al.  Direct Isolation of Satellite Cells for Skeletal Muscle Regeneration , 2005, Science.

[12]  J. Mendell,et al.  A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy , 2007, Journal of Translational Medicine.

[13]  I. Nonaka,et al.  Therapeutic trial with protease inhibitor (Leupeptin) in chicken muscular dystrophy , 1982, Acta Neuropathologica.

[14]  Toshio Miki,et al.  Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells , 2008, Stem cells.

[15]  S. Hamed.  Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy. , 2006, IDrugs : the investigational drugs journal.

[16]  F. Crea,et al.  Myogenic potential of adipose-tissue-derived cells , 2006, Journal of Cell Science.

[17]  V. Fossati,et al.  Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro , 2007, BMC Developmental Biology.

[18]  B. Brand-Saberi,et al.  Limb muscle development. , 2002, The International journal of developmental biology.

[19]  H. Broxmeyer,et al.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Socci,et al.  Derivation of Multipotent Mesenchymal Precursors from Human Embryonic Stem Cells , 2005, PLoS medicine.

[21]  M. Loeffler,et al.  Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. , 1990, Development.

[22]  J. Trelford,et al.  The amnion in surgery, past and present. , 1979, American journal of obstetrics and gynecology.

[23]  Guang-qian Zhou,et al.  Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead. , 2006, Chinese Medical Journal.

[24]  N. Bresolin,et al.  Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts , 2003, Science.

[25]  C. Maltin,et al.  Impact of manipulations of myogenesis in utero on the performance of adult skeletal muscle. , 2001, Reproduction.

[26]  H. Reichenspurner,et al.  Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells. , 2007, Stem cells and development.

[27]  S. Weiss,et al.  Is there a neural stem cell in the mammalian forebrain? , 1996, Trends in Neurosciences.

[28]  Mary Anne Wheeler,et al.  Stem , 1985 .

[29]  G. Kobinger,et al.  Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells. , 2003, Human gene therapy.

[30]  Yukio Nakamura,et al.  Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro , 2007, Human Cell.

[31]  K. Davies,et al.  Utrophin upregulation in Duchenne muscular dystrophy. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[32]  D. Duan.  Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. , 2006, Human molecular genetics.

[33]  B. Petrof.  Molecular Pathophysiology of Myofiber Injury in Deficiencies of the Dystrophin-Glycoprotein Complex , 2002, American journal of physical medicine & rehabilitation.

[34]  N. Parenteau,et al.  Epidermis generated in vitro: practical considerations and applications , 1991, Journal of cellular biochemistry.

[35]  M. Chopp,et al.  Treatment of Traumatic Brain Injury in Adult Rats with Intravenous Administration of Human Bone Marrow Stromal Cells , 2001, Neurosurgery.

[36]  C. Verfaillie,et al.  Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. , 2001, Blood.

[37]  M. Buckingham,et al.  The formation of skeletal muscle: from somite to limb , 2003, Journal of anatomy.

[38]  Ulrich Göbel,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use , 2004 .

[39]  H. Nakauchi,et al.  Adult mouse hematopoietic stem cells: purification and single-cell assays , 2006, Nature Protocols.

[40]  John McAnally,et al.  Regulation of HDAC9 Gene Expression by MEF2 Establishes a Negative-Feedback Loop in the Transcriptional Circuitry of Muscle Differentiation , 2006, Molecular and Cellular Biology.

[41]  F. Candotti,et al.  Engraftment Potential of Human Amnion and Chorion Cells Derived from Term Placenta , 2004, Transplantation.

[42]  Keelin O'Donoghue,et al.  Human Fetal Mesenchymal Stem Cells as Vehicles for Gene Delivery , 2005, Stem cells.

[43]  J. Chan,et al.  Widespread Distribution and Muscle Differentiation of Human Fetal Mesenchymal Stem Cells After Intrauterine Transplantation in Dystrophic mdx Mouse , 2007, Stem cells.

[44]  Giulio Cossu,et al.  Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs , 2006, Nature.

[45]  Johan T den Dunnen,et al.  Local dystrophin restoration with antisense oligonucleotide PRO051. , 2007, The New England journal of medicine.

[46]  B. Brunk,et al.  Sonic hedgehog controls epaxial muscle determination through Myf5 activation. , 1999, Development.

[47]  S. Bhasin,et al.  Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. , 2003, Endocrinology.

[48]  G. Prestwich,et al.  Nuclear Magnetic Resonance Metabolomic Footprinting of Human Hepatic Stem Cells and Hepatoblasts Cultured in Hyaluronan‐Matrix Hydrogels , 2008, Stem cells.

[49]  S. Xiao,et al.  Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice. , 2007, Human gene therapy.

[50]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[51]  H. Mizuno,et al.  Mesengenic potential and future clinical perspective of human processed lipoaspirate cells. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[52]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[53]  D. Fauza,et al.  The amniotic fluid as a source of cells for fetal tissue engineering. , 2001, Journal of pediatric surgery.

[54]  C. Zhang,et al.  Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice , 2008, BMC Cell Biology.

[55]  J. Wagner,et al.  Adult umbilical cord blood transplantation: a comprehensive review , 2006, Bone Marrow Transplantation.

[56]  P. Nido,et al.  Muscle engraftment of myogenic progenitor cells following intraarterial transplantation , 2006, Muscle & nerve.

[57]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[58]  Ana Jaklenec,et al.  Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. , 2008, Tissue engineering. Part A.

[59]  J. Niederkorn.  See no evil, hear no evil, do no evil: the lessons of immune privilege , 2006, Nature Immunology.

[60]  F. Luyten,et al.  Multipotent mesenchymal stem cells from adult human synovial membrane. , 2001, Arthritis and rheumatism.

[61]  O. Parolini,et al.  Isolation and characterization of mesenchymal cells from human fetal membranes , 2007, Journal of tissue engineering and regenerative medicine.

[62]  A. Uccelli,et al.  Mesenchymal stem cells: a new strategy for immunosuppression? , 2007, Trends in immunology.

[63]  N. Koizumi,et al.  Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction , 2002, Clinical and experimental immunology.

[64]  K. Tsuchida,et al.  Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  R. Brinster,et al.  Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[66]  W. Arap,et al.  A Population of Multipotent CD34-Positive Adipose Stromal Cells Share Pericyte and Mesenchymal Surface Markers, Reside in a Periendothelial Location, and Stabilize Endothelial Networks , 2008, Circulation research.

[67]  N. Bresolin,et al.  Intraarterial Injection of Muscle-Derived Cd34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice , 2001, The Journal of cell biology.

[68]  G. Bassez,et al.  Muscle satellite cells and endothelial cells: close neighbors and privileged partners. , 2007, Molecular biology of the cell.

[69]  M. Chopp,et al.  Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.

[70]  I. Weissman,et al.  Cell fate determination from stem cells , 2002, Gene Therapy.

[71]  G. Cossu,et al.  Wnt signaling and the activation of myogenesis in mammals , 1999, The EMBO journal.

[72]  G. Shefer,et al.  Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway , 2004, Journal of Cell Science.

[73]  M. Pera,et al.  Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential , 2007, Biology of reproduction.

[74]  T. Nikaido,et al.  Human Amniotic Mesenchymal Cells Have Some Characteristics of Cardiomyocytes , 2005, Transplantation.

[75]  Hung Li,et al.  Homing genes, cell therapy and stroke. , 2006, Frontiers in bioscience : a journal and virtual library.

[76]  Elaine Fuchs,et al.  Epidermal stem cells of the skin. , 2006, Annual review of cell and developmental biology.

[77]  S. Wilton.  PTC124, nonsense mutations and Duchenne muscular dystrophy , 2007, Neuromuscular Disorders.

[78]  S. Henning,et al.  Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. , 2005, Gastroenterology.

[79]  K. Stevenson,et al.  Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. , 2007, Journal of pediatric surgery.

[80]  Nancy Cheng,et al.  Human hepatic stem cells from fetal and postnatal donors , 2007 .

[81]  A. D. de Vries,et al.  Genetic complementation of human muscle cells via directed stem cell fusion. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[82]  Giselle Chamberlain,et al.  Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.

[83]  P. Bianco,et al.  Marrow stromal stem cells. , 2000, The Journal of clinical investigation.

[84]  K. Okumura,et al.  Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[85]  M. Rudnicki,et al.  Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[86]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[87]  D. Duan,et al.  Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin/Utrophin Expression , 2008, Circulation research.

[88]  A. Zeiher,et al.  Cell-enhancement strategies for the treatment of ischemic heart disease , 2007, Nature Clinical Practice Cardiovascular Medicine.

[89]  M. Yen,et al.  Placenta‐Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon‐γ , 2006, Stem cells.

[90]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[91]  B. Wong,et al.  Effect of Long-term Steroids on Cough Efficiency and Respiratory Muscle Strength in Patients With Duchenne Muscular Dystrophy , 2007, Pediatrics.

[92]  N. Corbi,et al.  Utrophin Up-Regulation by an Artificial Transcription Factor in Transgenic Mice , 2007, PloS one.

[93]  J. Ludlow,et al.  Hepatic stem cells and hepatoblasts: identification, isolation, and ex vivo maintenance. , 2008, Methods in cell biology.

[94]  S. Peltz,et al.  Safety, Tolerability, and Pharmacokinetics of PTC124, a Nonaminoglycoside Nonsense Mutation Suppressor, Following Single‐ and Multiple‐Dose Administration to Healthy Male and Female Adult Volunteers , 2007, Journal of clinical pharmacology.

[95]  Helen M Blau,et al.  Bone marrow contribution to skeletal muscle: a physiological response to stress. , 2005, Developmental biology.

[96]  B. Gawronska-Kozak,et al.  Ear mesenchymal stem cells (EMSC) can differentiate into spontaneously contracting muscle cells , 2007, Journal of cellular biochemistry.

[97]  Michael L Boninger,et al.  Functional overloading of dystrophic mice enhances muscle-derived stem cell contribution to muscle contractile capacity. , 2009, Archives of Physical Medicine and Rehabilitation.

[98]  S. Gerson,et al.  Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[99]  P. McCarthy,et al.  Monocyte Chemotactic Protein‐3 Is a Myocardial Mesenchymal Stem Cell Homing Factor , 2007, Stem cells.

[100]  M. van Griensven,et al.  Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. , 2007, Tissue engineering.

[101]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[102]  B. Péault,et al.  Embryonic development of the human hematopoietic system. , 2005, The International journal of developmental biology.

[103]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[104]  M. Rudnicki,et al.  Niche regulation of muscle satellite cell self-renewal and differentiation. , 2008, Cell stem cell.

[105]  C. Tabin,et al.  Local extrinsic signals determine muscle and endothelial cell fate and patterning in the vertebrate limb. , 2002, Developmental cell.

[106]  F. Torricelli,et al.  Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. , 1993, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia.

[107]  T. Rando,et al.  Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. , 2002, Human gene therapy.

[108]  J. Rousseau,et al.  Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[109]  Fabio Martelli,et al.  Enhanced Arteriogenesis and Wound Repair in Dystrophin-Deficient mdx Mice , 2004, Circulation.

[110]  E. Thomas,et al.  Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. , 1957, The New England journal of medicine.

[111]  Daniel J Garry,et al.  Muscle stem cells in development, regeneration, and disease. , 2006, Genes & development.

[112]  A I Caplan,et al.  The mesengenic process. , 1994, Clinics in plastic surgery.

[113]  D. Metcalf.  Concise Review: Hematopoietic Stem Cells and Tissue Stem Cells: Current Concepts and Unanswered Questions , 2007, Stem cells.

[114]  N. Bresolin,et al.  Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model , 2003, The Journal of cell biology.

[115]  Timothy J Gardner,et al.  Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. , 2007, American journal of physiology. Heart and circulatory physiology.

[116]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[117]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[118]  Roberto Bolli,et al.  Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology , 2006, Circulation.

[119]  M. Rojas,et al.  Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. , 2008, Expert opinion on biological therapy.

[120]  D. Discher,et al.  Extracellular matrix elasticity directs stem cell differentiation. , 2007, Journal of musculoskeletal & neuronal interactions.

[121]  M. Rudnicki,et al.  Stem cell based therapies to treat muscular dystrophy. , 2007, Biochimica et biophysica acta.

[122]  H. Blau,et al.  Migration of myoblasts across basal lamina during skeletal muscle development , 1990, Nature.

[123]  A. Stracher.  Calpain Inhibitors as Therapeutic Agents in Nerve and Muscle Degeneration , 1999, Annals of the New York Academy of Sciences.

[124]  Yaming Wang,et al.  Autotransplantation in mdx Mice of mdx Myoblasts Genetically Corrected by an HSV-1 Amplicon Vector , 2002, Cell transplantation.

[125]  M. Rojas,et al.  Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies , 2008, Expert opinion on biological therapy.

[126]  A. Pestronk,et al.  A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy , 2008, Annals of neurology.

[127]  D. Watt,et al.  Galectin‐1 Induces Skeletal Muscle Differentiation in Human Fetal Mesenchymal Stem Cells and Increases Muscle Regeneration , 2006, Stem cells.

[128]  F. Relaix.  Skeletal muscle progenitor cells: from embryo to adult , 2006, Cellular and Molecular Life Sciences CMLS.

[129]  C. Verfaillie,et al.  Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. , 2002, Experimental hematology.

[130]  J. Gillis.  An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice. , 2000, Acta neurologica Belgica.

[131]  I. Weissman,et al.  Direct isolation of human central nervous system stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[132]  M. Yen,et al.  Isolation of Multipotent Cells from Human Term Placenta , 2005, Stem cells.

[133]  Adam J. Engler,et al.  Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance , 2006 .

[134]  M. Pittenger,et al.  Adult mesenchymal stem cells: potential for muscle and tendon regeneration and use in gene therapy. , 2002, Journal of musculoskeletal & neuronal interactions.

[135]  F. Claas,et al.  Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. , 2003, Blood.

[136]  C. Hogaboam,et al.  The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease. , 2005, Pharmacology & therapeutics.

[137]  C. Dani,et al.  Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse , 2005, The Journal of experimental medicine.

[138]  I. Weissman,et al.  Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. , 2001, Annual review of cell and developmental biology.

[139]  A. Apessos,et al.  Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR , 2002, Prenatal diagnosis.

[140]  J. Tidball,et al.  The role of free radicals in the pathophysiology of muscular dystrophy. , 2007, Journal of applied physiology.

[141]  S. Tseng,et al.  Transplantation of Preserved Human Amniotic Membrane for Surface Reconstruction in Severely Damaged Rabbit Corneas , 1995, Cornea.

[142]  D R Jones,et al.  Adult mesenchymal stem cells: differentiation potential and therapeutic applications. , 2007, Journal of postgraduate medicine.

[143]  J. Huard,et al.  Muscle-derived stem cells: potential for muscle regeneration. , 2003, Birth defects research. Part C, Embryo today : reviews.

[144]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[145]  E. Clementi,et al.  Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy , 2007, Proceedings of the National Academy of Sciences.

[146]  M. Badalamente,et al.  Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition , 2000, Muscle & nerve.

[147]  Anthony Atala,et al.  De Novo Reconstitution of a Functional Mammalian Urinary Bladder by Tissue Engineering , 1999 .

[148]  A. Caplan,et al.  Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine , 1995, Muscle & nerve.

[149]  Giselle Chamberlain,et al.  Recent advances into the understanding of mesenchymal stem cell trafficking , 2007, British journal of haematology.

[150]  D. Allen,et al.  Intracellular calcium handling in ventricular myocytes from mdx mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[151]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[152]  Michelle Bradbury,et al.  Derivation of engraftable skeletal myoblasts from human embryonic stem cells , 2007, Nature Medicine.

[153]  K. Davies,et al.  Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer , 2003, Gene Therapy.

[154]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.

[155]  C. Voermans,et al.  Homing of human hematopoietic stem and progenitor cells: new insights, new challenges? , 2001, Journal of hematotherapy & stem cell research.

[156]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[157]  G. E. Jones,et al.  Conversion of dermal fibroblasts to a myogenic lineage is induced by a soluble factor derived from myoblasts , 1996, Journal of cellular biochemistry.

[158]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[159]  Irving L. Weissman,et al.  Shifting foci of hematopoiesis during reconstitution from single stem cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[160]  Q. Han,et al.  Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. , 2007, Stem cells and development.

[161]  Anthony Atala,et al.  De novo reconstitution of a functional mammalian urinary bladder by tissue engineering , 1999, Nature Biotechnology.

[162]  B. Sacchetti,et al.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells , 2007, Nature Cell Biology.

[163]  M. Brent,et al.  Molecular Properties of Adult Mouse Gastric and Intestinal Epithelial Progenitors in Their Niches* , 2006, Journal of Biological Chemistry.

[164]  Ulrich H. von Andrian,et al.  Stem Cell Trafficking in Tissue Development, Growth, and Disease , 2008, Cell.

[165]  M. Buckingham.  Muscle Differentiation: Which myogenic factors make muscle? , 1994, Current Biology.

[166]  J. Chamberlain,et al.  Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin , 2005, Gene Therapy.

[167]  F. Guilak,et al.  Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. , 2003, Cytotherapy.

[168]  L. De Angelis,et al.  Skeletal Myogenic Progenitors Originating from Embryonic Dorsal Aorta Coexpress Endothelial and Myogenic Markers and Contribute to Postnatal Muscle Growth and Regeneration , 1999, The Journal of cell biology.

[169]  A. Mauro.  SATELLITE CELL OF SKELETAL MUSCLE FIBERS , 1961, The Journal of biophysical and biochemical cytology.

[170]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[171]  A. Caplan.  Adult mesenchymal stem cells for tissue engineering versus regenerative medicine , 2007, Journal of cellular physiology.

[172]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[173]  B. Petrof.  The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy , 1998, Molecular and Cellular Biochemistry.

[174]  G. Invernici,et al.  Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. , 2007, The American journal of pathology.

[175]  S. Hwang,et al.  Skeletal Myogenic Differentiation of Mesenchymal Stem Cells Isolated from Human Umbilical Cord Blood , 2004, Stem cells.

[176]  T. Shimazaki,et al.  [Mammalian neural stem cells]. , 2008, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[177]  G. Cossu.  Fusion of bone marrow-derived stem cells with striated muscle may not be sufficient to activate muscle genes. , 2004, The Journal of clinical investigation.

[178]  S. Salani,et al.  Skeletal muscle differentiation potential of human adult bone marrow cells. , 2004, Experimental cell research.